The collaboration aims to deliver real-time image processing, robotic control and cloud-enabled intelligence in a unified ...
Acquisition is expected to strengthens Thermo Fisher’s position in delivering clinical information to pharma and biotech ...
Trial will evaluate the safety and effectiveness of the AtriCure Isolator® Synergy™ EnCompass® clamp and AtriClip® Left ...
Examines the increasing strain on caregivers in home-based care models, the level of support they need for various stages of care, and how improved technological devices and infrastructure can help ...
Hospitals are adding more connected devices than ever before—from patient wearables to asset tracking systems. Yet this ...
Rejected by leading customers Physicians as customers/intermediary complicates adoption pathways. Emerges in niche/small markets Sophisticated epidemiology and real-world data allow larger initial ...
Bryan Gilpin is President of Suntra MedTech Solution. He’s a hands-on, engineering-oriented executive with experience developing, manufacturing, selling, distributing and supporting bio-medical ...
For over three decades, Sunrise Labs stood at the forefront of engineering excellence and medical innovation. Today, the company unveils its new identity: Suntra MedTech Solutions™, a bold evolution ...
A comprehensive update on the combination products market shows significant industry partnerships, development challenges, and strategic imperatives for success in the sector characterized by dynamic ...
The nationwide study will assess the safety and efficacy of the technology that combines standard balloon dilation to open the respiratory tract with drug delivery designed to maintain symptom relief.
The MedTech industry has seen significant growth and raised expectations as it adapts to evolving healthcare needs in the wake of the COVID-19 pandemic. The industry’s ability to make technology a ...
The Problem: A Rigid, Risk-Prone Development Model The industry’s heavy reliance on waterfall project management has resulted in long, siloed, and high-risk product development cycles. This model does ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results